All that is true as long as they don't delay the release of their revenue generating products. In the interim they should have more than enough money to continue with their research. I think Rhinegold is partly correct in that the share price of the stock and overall confidence in the company does matter...if they need to raise more funds in the future. But once revenues start coming in it will ease the need to raise more funds.